Richard J. Hamilton

Richard J. Hamilton

Auto-generated profile, based on publicly available information

Richard J. Hamilton

Drexel University College of Medicine, Department of Emergency Medicine, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2004 in American Journal of Industrial Medicine
Verified
Journal Article
Closed access
PDF file
RHRobert G. Hendrickson
Robert G. Hendrickson
ACArthur Chang
Arthur Chang
RHRichard J. Hamilton
Richard J. Hamilton

1 March 1998 in Academic Emergency Medicine
Verified
Journal Article
Closed access
PDF file
RCRobert S. Chang
Robert S. Chang
RHRichard J. Hamilton
Richard J. Hamilton
WCWallace A. Carter
Wallace A. Carter

1 March 1996 in Academic Emergency Medicine
Verified
Journal Article
Open access
PDF file
RHRichard J. Hamilton
Richard J. Hamilton
WCWallace A. Carter
Wallace A. Carter
EGE. John Gallagher
E. John Gallagher
Objective: To test the hypothesis that sublingual captopril produces a more rapid improvement of acute pulmonary edema (APE) than does placebo, when added to a standard regimen of O2, nitrates, morphine, and furosemide.Methods: Prospective, randomized, double‐blind, placebo‐controlled clinical trial in an urban teaching hospital ED. Adults brought to the ED with APE were given captopril or placebo sublingually Every 5 minutes a clinical APE distress score (APEX) was obtained.Results: Over the first 40 minutes of treatment, the mean APEXs were significantly better for the patients given captopril [p < 0. 001, F = 14. 5, one‐way (repeated‐measures) analysis of variance (ANOVA)]. At 30 minutes, the patients given captopril had a mean APEX improvement of 43% (i. e., to 57% of initial distress); the group given the current standard regimen plus placebo improved only 25% (i. e., to 75% of initial distress; p = 0. 03, multiway ANOVA). In addition, there was less respiratory failure necessitating mechanical ventilation in the captopril patients (9%) vs the placebo patients (20%), which did not achieve significance (p = 0. 10, Fisher's exact test).Conclusion: In APE, the addition of sublingual captopril to the standard regimen of O2, nitrates, morphine, and furosemide produces more rapid clinical improvement than does the standard regimen alone.

1 October 2012 in Aviation, Space, and Environmental Medicine
Verified
Journal Article
Closed access
RBRebecca S. Blue
Rebecca S. Blue
JRJon M. Riccitello
Jon M. Riccitello
JTJulia Tizard
Julia Tizard
RHRichard J. Hamilton
Richard J. Hamilton
JVJames M. Vanderploeg
James M. Vanderploeg
Blue RS, Riccitello JM, Tizard J, Hamilton RJ, Vanderploeg JM. Commercial spaceflight participant G-force tolerance during centrifuge-simulated suborbital flight. Aviat Space Environ Med 2012; 83:929–34. Introduction: Medical knowledge of the human body in microgravity and hypergravity is based upon studies of healthy individuals well-conditioned for such environments. Little data exist regarding the effects of spaceflight on untrained commercial passengers. We examined the responses of potential spaceflight participants (SFP) to centrifuge G-force exposure. Methods: There were 77 individuals (65 men, 12 women), 22-88 yr old, who underwent 6 centrifuge runs over 48 h. Day 1 consisted of two +Gz runs (peak = 3.5+Gz, run 2) and two +Gx runs (peak = 6.0+Gx, run 4). Day 2 consisted of two runs approximating a suborbital spaceflight profile. Data included blood pressure, electrocardiogram, and postrun questionnaires regarding motion sickness, disorientation, greyout, and other symptoms. Results: Of the 77 participants, average age was 50.4 ± 12.7 yr. Average heart rate (HR) varied by sex and direction of G-exposure (+Gz: F 150 ± 19, M 123 ± 27; +Gx: F 135 ± 30, M 110 ± 27). Age and peak HR were inversely related (HR < 120bpm: 60.2 ± 12.2 yr, HR > 120: 47.1 ± 10.9 yr). HR during peak G-exposure for the final run was associated with post-run imbalance (no imbalance: HR 126 ± 26, imbalance: HR 145 ± 21); no other significant hemodynamic change, sex, or age variation was associated with imbalance. Age and greyout were inversely associated; there was no association between greyout and vital sign change, sex, or G-force magnitude. Baseline/pretrial mean arterial pressure (MAP) was not associated with any symptoms. Discussion: The results suggest that most individuals with well-controlled medical conditions can withstand acceleration forces involved in launch/landing profiles of commercial spaceflight vehicles. Further investigation will help refine which conditions present significant risk during suborbital flight and beyond.

1 January 2000 in Journal of Toxicology: Clinical Toxicology
Verified
Journal Article
Closed access
RHRichard J. Hamilton
Richard J. Hamilton
JPJeanmarie Perrone
Jeanmarie Perrone
RHRobert Hoffman
Robert Hoffman
FHFred M. Henretig
Fred M. Henretig
EKEb H. Karkevandian
Eb H. Karkevandian
KNKaren Nordenholz
Karen Nordenholz
(2000). A Descriptive Study of an Epidemic of Poisoning Caused by Heroin Adulterated with Scopolamine. Journal of Toxicology: Clinical Toxicology: Vol. 38, No. 6, pp. 597-608.

1 January 1996 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
FVFrank Lo Vecchio
Frank Lo Vecchio
RHRichard J Hamilton
Richard J Hamilton
RHRobert J Hoffman
Robert J Hoffman